BR112013007566A2 - novos compostos bicíclicos - Google Patents

novos compostos bicíclicos

Info

Publication number
BR112013007566A2
BR112013007566A2 BR112013007566A BR112013007566A BR112013007566A2 BR 112013007566 A2 BR112013007566 A2 BR 112013007566A2 BR 112013007566 A BR112013007566 A BR 112013007566A BR 112013007566 A BR112013007566 A BR 112013007566A BR 112013007566 A2 BR112013007566 A2 BR 112013007566A2
Authority
BR
Brazil
Prior art keywords
formula
compounds
gpcr
polymorphs
prodrugs
Prior art date
Application number
BR112013007566A
Other languages
English (en)
Portuguese (pt)
Inventor
Jagattaran Das
Nishan Singh
Rajesh Jain
Sanjay Trehan
Sudhir Kumar Sharma
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of BR112013007566A2 publication Critical patent/BR112013007566A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
BR112013007566A 2010-09-28 2011-09-27 novos compostos bicíclicos BR112013007566A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2322DE2010 2010-09-28
IN1515DE2011 2011-05-26
PCT/IN2011/000669 WO2012042539A2 (en) 2010-09-28 2011-09-27 Novel bicyclic compounds

Publications (1)

Publication Number Publication Date
BR112013007566A2 true BR112013007566A2 (pt) 2016-08-02

Family

ID=45048157

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013007566A BR112013007566A2 (pt) 2010-09-28 2011-09-27 novos compostos bicíclicos

Country Status (6)

Country Link
US (1) US9133116B2 (https=)
EP (1) EP2621902B1 (https=)
JP (1) JP2013542929A (https=)
AR (1) AR083202A1 (https=)
BR (1) BR112013007566A2 (https=)
WO (1) WO2012042539A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012125661A1 (en) * 2011-03-17 2012-09-20 Merck Sharp & Dohme Corp. Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists
JP5936849B2 (ja) * 2011-11-24 2016-06-22 東洋ゴム工業株式会社 空気入りタイヤの製造方法
JP6526034B2 (ja) * 2014-02-14 2019-06-05 武田薬品工業株式会社 Ｇｐｒ６のピリドピラジンモジュレーター
US9575560B2 (en) 2014-06-03 2017-02-21 Google Inc. Radar-based gesture-recognition through a wearable device
US9811164B2 (en) 2014-08-07 2017-11-07 Google Inc. Radar-based gesture sensing and data transmission
US10268321B2 (en) 2014-08-15 2019-04-23 Google Llc Interactive textiles within hard objects
US11169988B2 (en) 2014-08-22 2021-11-09 Google Llc Radar recognition-aided search
US9778749B2 (en) 2014-08-22 2017-10-03 Google Inc. Occluded gesture recognition
US9600080B2 (en) 2014-10-02 2017-03-21 Google Inc. Non-line-of-sight radar-based gesture recognition
EP3289434A1 (en) 2015-04-30 2018-03-07 Google LLC Wide-field radar-based gesture recognition
KR102011992B1 (ko) 2015-04-30 2019-08-19 구글 엘엘씨 타입-애그노스틱 rf 신호 표현들
CN111522434B (zh) 2015-04-30 2024-12-10 谷歌有限责任公司 用于手势跟踪和识别的基于rf的微运动跟踪
US9693592B2 (en) 2015-05-27 2017-07-04 Google Inc. Attaching electronic components to interactive textiles
US10088908B1 (en) 2015-05-27 2018-10-02 Google Llc Gesture detection and interactions
US10817065B1 (en) 2015-10-06 2020-10-27 Google Llc Gesture recognition using multiple antenna
WO2017112792A1 (en) * 2015-12-22 2017-06-29 Takeda Pharmaceutical Company Limited Tripartite modulators of endosomal g protein-coupled receptors
WO2017192167A1 (en) 2016-05-03 2017-11-09 Google Llc Connecting an electronic component to an interactive textile
US10175781B2 (en) 2016-05-16 2019-01-08 Google Llc Interactive object with multiple electronics modules
US10285456B2 (en) 2016-05-16 2019-05-14 Google Llc Interactive fabric
WO2018053587A1 (en) * 2016-09-21 2018-03-29 Vectus Biosystems Limited Compositions for the treatment of hypertension and/or fibrosis
US10579150B2 (en) 2016-12-05 2020-03-03 Google Llc Concurrent detection of absolute distance and relative movement for sensing action gestures
TWI860849B (zh) 2021-09-14 2024-11-01 美商美國禮來大藥廠 Sstr4促效劑鹽

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435419A (en) 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
US4438130A (en) 1981-11-12 1984-03-20 The Upjohn Company Analgesic 1-oxa-, aza- and thia-spirocyclic compounds
US4560767A (en) 1983-06-17 1985-12-24 The Upjohn Company N-(2-amino-cycloalkenyl)benzeneacetamide and -benzamide analgesics and tritiated kappa agonists therefrom
IE66202B1 (en) 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
WO1995021820A1 (en) 1994-02-10 1995-08-17 Yamanouchi Pharmaceutical Co., Ltd. Novel carbamate derivative and medicinal composition containing the same
US5475116A (en) * 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
GB9524157D0 (en) 1995-11-25 1996-01-24 Pfizer Ltd Therapeutic agents
PT891332E (pt) 1996-03-29 2004-07-30 Pfizer Derivados de 6-fenilpiridil-2-amina
US5914338A (en) 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5968929A (en) 1996-10-30 1999-10-19 Schering Corporation Piperazino derivatives as neurokinin antagonists
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
US20030207876A1 (en) 2000-06-23 2003-11-06 Banks Bernard Joseph 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
GB0015562D0 (en) 2000-06-23 2000-08-16 Pfizer Ltd Heterocycles
US7125887B2 (en) 2000-10-11 2006-10-24 Merck & Co., Inc. Pyrrolidine modulators of CCR5 chemokine receptor activity
US6372919B1 (en) 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
ES2248633T3 (es) 2001-04-17 2006-03-16 MERCK & CO., INC. Antibioticos oxazolidinona que contienen biciclo (3,1,o)hexano y derivados de los mismos.
US20030232739A1 (en) 2001-08-15 2003-12-18 Pfizer Inc. Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist
EP1440059B1 (en) 2001-10-22 2008-04-16 Pfizer Products Inc. 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
GB0208897D0 (en) 2002-04-18 2002-05-29 Merck Sharp & Dohme New method of treatment
AU2002345266B2 (en) 2002-07-08 2009-07-02 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
HK1079708A1 (zh) 2002-08-09 2006-04-13 Ranbaxy Laboratories, Ltd. 可用作毒蕈碱性受体拮抗剂的3，6-二取代氮杂二环[3．1．10]己烷衍生物
JP2006501236A (ja) 2002-08-23 2006-01-12 ランバクシー ラボラトリーズ リミテッド ムスカリン性レセプター拮抗薬としてのフルオロおよびスルホニルアミノ含有３，６−二置換アザビシクロ（３．１．０）ヘキサン誘導体
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
WO2004056810A1 (en) 2002-12-23 2004-07-08 Ranbaxy Laboratories Limited Xanthine derivatives as muscarinic receptor antagonists
BRPI0409217A (pt) 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
EA009387B1 (ru) 2003-04-11 2007-12-28 Рэнбакси Лабораториз Лимитед Азабициклические производные в качестве антагонистов мускаринового рецептора
CA2529294A1 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
DE602004027811D1 (de) 2003-07-02 2010-08-05 Kyorin Seiyaku Kk Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
EP1654259A1 (en) 2003-07-02 2006-05-10 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
WO2005005399A1 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
WO2005026121A1 (en) 2003-09-18 2005-03-24 Ranbaxy Laboratories Limited PROCESS FOR THE PREPARATION OF (1α, 5α, 6α)-6-AMINOMETHYL-3-BENZYL-3-AZABICYCLO[3.1.0]HEXANE
US7153976B2 (en) 2003-10-06 2006-12-26 Pfizer Inc. Purification process for an azabicyclo[3.1.0]hexane compound
KR20060095865A (ko) 2003-10-14 2006-09-04 화이자 프로덕츠 인크. 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
RU2006112576A (ru) 2003-10-16 2006-08-27 Пфайзер Продактс Инк. (Us) Получение производных 3-азабицикло [3.1.0] гексана
CN103102389A (zh) 2004-02-27 2013-05-15 默沙东公司 作为丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的硫化合物
US20050282859A1 (en) 2004-06-04 2005-12-22 Thor Karl B Dual acting SNRI-NMDA antagonists for the treatment of genitourinary disorders
CN101005838A (zh) 2004-06-22 2007-07-25 先灵公司 大麻素受体配体
MX2007002136A (es) 2004-09-01 2007-04-02 Pfizer Prod Inc Antagonistas amino azabiciclicos del receptor 3 de la histamina.
CA2580621A1 (en) 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
WO2006054162A1 (en) 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Azabicyclic muscarinic receptor antagonists
WO2006064304A1 (en) 2004-12-15 2006-06-22 Ranbaxy Laboratories Limited Acid addition salts of muscarinic receptor antagonists
US20060223875A1 (en) 2005-03-08 2006-10-05 Phil Skolnick Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3.1.0]hexanes
ES2520015T3 (es) 2005-04-08 2014-11-11 Pfizer Products Inc. [3.1.0]Heteroaril amidas bicíclicas como inhibidores de transporte de glicina de tipo 1
EP1888525A1 (en) 2005-05-03 2008-02-20 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives as muscarinic receptor antagonists
GB0510204D0 (en) 2005-05-19 2005-06-22 Chroma Therapeutics Ltd Enzyme inhibitors
WO2007007282A2 (en) 2005-07-11 2007-01-18 Ranbaxy Laboratories Limited Azabicyclo derivatives as muscarinic receptor antagonists
WO2007006117A1 (en) 2005-07-13 2007-01-18 Nicogen Inc. Novel cyp2a6 inhibitors
US20070082939A1 (en) 2005-07-26 2007-04-12 Lippa Arnold S Methods and compositions for the treatment of neuropathies and related disorders
NZ592836A (en) 2005-07-27 2013-01-25 Dov Pharmaceutical Inc Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
WO2007127421A2 (en) 2006-04-28 2007-11-08 Merck & Co., Inc. Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes
WO2007135527A2 (en) 2006-05-23 2007-11-29 Pfizer Products Inc. Benzimidazolyl compounds
WO2007135529A2 (en) 2006-05-23 2007-11-29 Pfizer Products Inc. Azabenzimidazolyl compounds as mglur2 potentiators
WO2007138431A2 (en) 2006-05-30 2007-12-06 Pfizer Products Inc. Azabicyclic ether histamine-3 antagonists
US20080058535A1 (en) 2006-07-25 2008-03-06 Zhengming Chen Methods and compositions for production, formulation and use of 1 aryl-3-azabicyclo[3.1.0]hexanes
EP2059505A2 (en) 2006-09-04 2009-05-20 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
US8962825B2 (en) 2006-10-30 2015-02-24 Glaxosmithkline Intellectual Property Development Limited Hydroxamates as inhibitors of histone deacetylase
WO2008075162A2 (en) 2006-12-15 2008-06-26 Pfizer Limited Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
GB0625198D0 (en) * 2006-12-18 2007-01-24 Glaxo Group Ltd Chemical compounds
US20080287479A1 (en) 2006-12-20 2008-11-20 Pfizer Inc Inhibitors of serine palmitoyltransferase
US20080176860A1 (en) 2007-01-19 2008-07-24 Lutz Weber Pyridin-2-one compounds
WO2008117229A1 (en) 2007-03-23 2008-10-02 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
EP1980150A1 (en) 2007-04-13 2008-10-15 Basf Se Fungicidal mixtures based on triazolopyrimidine compounds
US20090069374A1 (en) 2007-06-06 2009-03-12 Phil Skolnick Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
JP2009040709A (ja) 2007-08-08 2009-02-26 Kyorin Pharmaceut Co Ltd １２位置換ムチリン誘導体
GB0716632D0 (en) 2007-08-24 2007-10-03 Glaxo Group Ltd Compounds
TW200924781A (en) 2007-09-14 2009-06-16 Janssen Pharmaceutica Nv Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
WO2009090548A2 (en) 2008-01-17 2009-07-23 Glenmark Pharmaceuticals, S.A. 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
US8278311B2 (en) 2008-04-28 2012-10-02 Abbott Laboratories Substituted pyrimidine derivatives
GB0809479D0 (en) 2008-05-23 2008-07-02 Glaxo Group Ltd Novel compounds
US20120108565A1 (en) 2008-07-30 2012-05-03 Lalima Sharma Pyrrole carboxylic acid derivatives as antibacterial agents
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
BR112012000657A2 (pt) 2009-06-26 2016-11-16 Panacea Biotec Ltd novos azabicilohexanos

Also Published As

Publication number Publication date
WO2012042539A3 (en) 2012-05-31
US20130253029A1 (en) 2013-09-26
WO2012042539A2 (en) 2012-04-05
JP2013542929A (ja) 2013-11-28
EP2621902A2 (en) 2013-08-07
EP2621902B1 (en) 2017-04-12
AR083202A1 (es) 2013-02-06
US9133116B2 (en) 2015-09-15

Similar Documents

Publication Publication Date Title
BR112013007566A2 (pt) novos compostos bicíclicos
CL2020001576A1 (es) Componentes heterocíclicos bicíclicos sustituidos como inhibidores de prmt5.
DOP2015000158A (es) Inhibidores de prmt5 y sus usos
BR112016006151A2 (pt) imidazopiridazinas úteis como inibidores da via de sinalização do par-2
MX2017011951A (es) Derivados sustituidos de indol 3 novedosos, composiciones farmaceuticas y metodos para uso.
MY202022A (en) Pyrrolotriazine compounds as tam inhibitors
WO2013038429A3 (en) Novel sglt inhibitors
UY32480A (es) Derivados de benzofuranilo
MX336549B (es) Compuestos de 2-amino-4-ariltiazol como antagonistas de trpa1.
BR112016000909A8 (pt) derivados piperidinil indólicos, seus usos, e combinação e composição farmacêuticas
EA201390969A1 (ru) Модуляторы глюкагонового рецептора
BR112016016844A2 (pt) Compostos heterocíclicos
MX2013012776A (es) Inhibidores de la tirosina cinasa de bazo que contienen aminopiridina.
MX2012000231A (es) Nuevos aza-biciclo-hexanos.
EA201490807A1 (ru) Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1
ECSP20024651A (es) Derivados de imidazol condensados sustituidos por grupos de hidroxilo terciario como inhibidores de gamma pi3k-y
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
NI201300072A (es) Derivados de heteroarilo como moduladores nachr alfa 7
CO6321281A2 (es) Derivados de tetrazol como moduladores de receptores de glutamato metabotropicos (mglurs)
MX353209B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
EA201490754A1 (ru) Производные карбамата/мочевины, содержащие пиперидиновые и пиперазиновые кольца, в качестве ингибиторов н3 рецептора
WO2012172566A3 (en) Novel sglt inhibitors
WO2009118765A8 (en) Novel monoamine re-uptake inhibitor
BR112016018418A2 (pt) Composto, uso do mesmo, e composição farmacêutica
BR112016017816A8 (pt) derivados de etinila, seus usos, e composição farmacêutica

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 3A, 4A E 5A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.